aspirin has been researched along with 25-hydroxyvitamin d 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bishop, DT; Chan, M; Davies, JR; Gascoyne, J; Haynes, S; Latheef, F; Newton-Bishop, JA; O'Donovan, C; Randerson-Moor, J; Waseem, S | 1 |
1 other study(ies) available for aspirin and 25-hydroxyvitamin d 2
Article | Year |
---|---|
25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.
Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcifediol; Comorbidity; Female; Follow-Up Studies; Humans; Inflammation; Male; Melanoma; Middle Aged; Multivariate Analysis; Smoking; Survival Analysis; Treatment Outcome; Ulcer; United Kingdom; Young Adult | 2015 |